FHTX FY 2020 Earnings — Foghorn Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

FHTXFoghorn Therapeutics Inc.

$322M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$430,000

Gross Profit

-$57M-13322.1% margin

Operating Income

-$69M-15937.4% margin

Net Income

-$69M-16000.0% margin

EPS (Diluted)

$-1.90

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$47M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$256M

Total Liabilities

$109M

Stockholders' Equity

$146M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$430,000	$0	—
Gross Profit	-$57M	-$2M	-3094.9%
Operating Income	-$69M	-$51M	-34.2%
Net Income	-$69M	-$51M	-34.6%